Amplifi Vascular, Inc.
About
Issuer
- Entity type
- Corporation
- Jurisdiction
- Delaware
- Sector
- Biotech
- Headquarters
- Prairie Village, KS
- Street
- 3965 West 83rd Street, #300
- Zip
- 66208
Offering
- Total offering
- $6M
- Amount sold
- $5.9M
- First sale
- Aug 21, 2024
- Min investment
- $0
- Securities
- Debt
- Federal exemption
- Rule 506(b)
- Investors so far
- 59
How this filing compares
Ranked #10 of 23 Biotech filings in March 2026 by offering amount.
Median Biotech filing in March 2026: $5.4M. This offering is 1.1× the median.
Other Kansas filings this week: Blackthorn Partners L.P., Tier One & Associates, LP, Aspiria Land Development, LLC, LULA SMARTER PROPERTY MAINTENANCE, INC., Dynamo Capital LLC
Leadership
Sean Morris — Executive Officer (also: Director)
Also named on: Cultivation Capital Life Sciences Fund IV, LP
Nathaniel Hagedorn — Director
Also named on: NorthPoint Industrial Fund VII, LP, NorthPoint Industrial Fund VII, LP, NorthPoint Industrial Fund VII, LP, NorthPoint Industrial Fund VII, LP, NP Industrial VII Blocker Feeder, LP
James Schultz — Director
Steve Braun — Director
Filing details
Amplifi Vascular, Inc. filed a Form D with the SEC on March 26, 2026.